Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global Non-Invasive Prenatal Testing (NIPT) Market, 2016 2022 (USD Million)

2.2. Global Non-Invasive Prenatal Testing (NIPT) Market: Snapshot

Chapter 3. Non-Invasive Prenatal Testing (NIPT) Market Market Dynamics


3.1. Introduction

3.2. Market Drivers


3.2.1. Global NIPT Market drivers: Impact analysis

3.2.2. Rapid increase in genetic disorders/abnormalities

3.2.3. Increase in global average maternal age and awareness among parents

3.2.4. Expansion of coverage by payers to low and average-risk pregnancies

3.3. Market Restraints


3.3.1. Global NIPT Market restraints: Impact analysis

3.3.2. Records of drug abuse

3.3.3. High test cost

3.3.4. Stringent usage regulations

3.4. Opportunities


3.4.1. Increasing awareness about NIPT tests and improving healthcare facilities in developing countries

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by species type segment

3.6.2. Market attractiveness analysis, by drug class segment

3.6.3. Market attractiveness analysis, by mode of administration segment

3.6.4. Market attractiveness analysis, by end-user segment

3.6.5. Market attractiveness analysis, by regional segment

Chapter 4. Global Non-Invasive Prenatal Testing (NIPT) Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global Non-Invasive Prenatal Testing (NIPT) Market: company market share, 2016

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Test Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development and Regional Expansion

4.3. Price Trend Analysis

Chapter 5. Global Non-Invasive Prenatal Testing (NIPT) Market Test Type Segment Analysis


5.1. Global non-invasive prenatal testing (NIPT) market: test type overview


5.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by test type, 2016 and 2022

5.2. Panel 1


5.2.1. Global non-invasive prenatal testing (NIPT) market for panel 1 market, 2016 2022 (USD Million)

5.3. Panel 2


5.3.1. Global non-invasive prenatal testing (NIPT) market for panel 2 market, 2016 2022 (USD Million)

5.4. Panel 3


5.4.1. Global non-invasive prenatal testing (NIPT) market for panel 3 market, 2016 2022 (USD Million)

Chapter 6. Global Non-Invasive Prenatal Testing (NIPT) Market End-user Segment Analysis


6.1. Global non-invasive prenatal testing (NIPT) market: end-user overview


6.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by end-user, 2016 and 2022

6.2. Hospitals


6.2.1. Global non-invasive prenatal testing (NIPT) market for hospitals 2016 2022 (USD Million)

6.3. Diagnostic Centers


6.3.1. Global non-invasive prenatal testing (NIPT) market for diagnostic centers, 2016 2022 (USD Million)

6.4. Maternity Clinics


6.4.1. Global non-invasive prenatal testing (NIPT) market for maternity clinics end-users, 2016 2022 (USD Million)

Chapter 7. Global Non-Invasive Prenatal Testing (NIPT) Market Regional Segment Analysis


7.1. Global non-invasive prenatal testing (NIPT) market: regional overview


7.1.1. Global non-invasive prenatal testing (NIPT) market revenue share, by region, 2016 and 2022

7.2. North America


7.2.1. North America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.2.2. North America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.2.3. U.S.


7.2.3.1. U.S. Non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.2.3.2. U.S. Non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.2.4. Canada


7.2.4.1. Canada non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.2.4.2. Canada non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.2.5. Rest of North America


7.2.5.1. Rest of North America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.2.5.2. Rest of North America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3. Europe


7.3.1. Europe non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.2. Europe non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.3. Germany


7.3.3.1. Germany non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.3.2. Germany non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.4. U.K.


7.3.4.1. U.K. Non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.4.2. U.K. Non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.5. France


7.3.5.1. France non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.5.2. France non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.6. Italy


7.3.6.1. Italy non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.6.2. Italy non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.7. Spain


7.3.7.1. Spain non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.7.2. Spain non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.8. Russia


7.3.8.1. Russia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.8.2. Russia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.3.9. Rest of Europe


7.3.9.1. Rest of Europe non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.3.9.2. Rest of Europe non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4. Asia Pacific


7.4.1. Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.4.2. Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4.3. China


7.4.3.1. China non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022(USD Million)

7.4.3.2. China non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4.4. Japan


7.4.4.1. Japan non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.4.4.2. Japan non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4.5. India


7.4.5.1. India non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.4.5.2. India non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4.6. Australia


7.4.6.1. Australia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.4.6.2. Australia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.4.7. Rest of Asia Pacific


7.4.7.1. Rest of Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.4.7.2. Rest of Asia Pacific non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.5. Latin America


7.5.1. Latin America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.5.2. Latin America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.5.3. Brazil


7.5.3.1. Brazil non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.5.3.2. Brazil non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.5.4. Mexico


7.5.4.1. Mexico non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.5.4.2. Mexico non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.5.5. Argentina


7.5.5.1. Argentina non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.5.5.2. Argentina non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.5.6. Rest of Latin America


7.5.6.1. Rest of Latin America non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.5.6.2. Rest of Latin America non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6. Middle East and Africa


7.6.1. Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.2. Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6.3. Saudi Arabia


7.6.3.1. Saudi Arabia non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.3.2. Saudi Arabia non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6.4. UAE


7.6.4.1. UAE non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.4.2. UAE non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6.5. Qatar


7.6.5.1. Qatar non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.5.2. Qatar non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6.6. South Africa


7.6.6.1. South Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.6.2. South Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)

7.6.7. Rest of Middle East and Africa


7.6.7.1. Rest of Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by test type, 2016 2022 (USD Million)

7.6.7.2. Rest of Middle East and Africa non-invasive prenatal testing (NIPT) market revenue, by end-user, 2016 2022 (USD Million)


Chapter 8. Company Profile


8.1. Ariosa Diagnostics, Inc.


8.1.1. Overview

8.1.2. Financials

8.1.3. Test portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. Berry Genomics Co., Ltd.


8.2.1. Overview

8.2.2. Financials

8.2.3. Test portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. BGI Diagnostics


8.3.1. Overview

8.3.2. Financials

8.3.3. Test portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. Illumina, Inc.


8.4.1. Overview

8.4.2. Financials

8.4.3. Test portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. LifeCodexx AG


8.5.1. Overview

8.5.2. Financials

8.5.3. Test portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Natera, Inc.


8.6.1. Overview

8.6.2. Financials

8.6.3. Test portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. Sequenom Laboratories


8.7.1. Overview

8.7.2. Financials

8.7.3. Test portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. Quest Diagnostics, Inc.


8.8.1. Overview

8.8.2. Financials

8.8.3. Test portfolio

8.8.4. Business strategy

8.8.5. Recent developments